Who is sponsoring PROPH-ITA?

PROPH-ITA is sponsored by Associazione Italiana per lo Studio del Pancreas.

What condition does PROPH-ITA study?

PROPH-ITA studies Candidates for Hereditary Pancreatic Cancer Testing.

What drugs are being tested in PROPH-ITA?

Interventions: Saliva swab testing.

What is the status of PROPH-ITA?

PROPH-ITA is currently RECRUITING.

Last reviewed 2023-02-15 · How we verify

Familial Pancreatic Cancer PROPHilation Program in Italy (PROPH-ITA)

NCT05724992 NA RECRUITING

The goal of the PROPH-ITA Study is to perform genetic testing in family members of pancreatic cancer patients who may have a genetic predisposition. The subjects belong to the Italian Registry of Families At Risk of Pancreatic Cancer (IRFARPC, #NCT04095195). This investigational study will assess the genetic background of subjects with familiarity with pancreatic cancer only. Participants may accept to undergo genetic testing as part of the IRFARPC registry, through a saliva-swab-based 41-gene panel test. Up to 3,000 participants will be enrolled in this study.

Details

Lead sponsor	Associazione Italiana per lo Studio del Pancreas
Phase	NA
Status	RECRUITING
Enrolment	3000
Start date	Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Dec 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Candidates for Hereditary Pancreatic Cancer Testing

Interventions

Saliva swab testing

Countries

Italy